Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84f43b5991d7d7449a7951a15c2108ce |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3679 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-521 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-3219 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-3274 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-523 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-3202 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J20-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-36 |
filingDate |
2012-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2021-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c83507c251f526721d55076c84ef964 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a7aa98eb7e0ff1d01b8874e9e042b0c |
publicationDate |
2021-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2801901-T3 |
titleOfInvention |
Treatment of conditions associated with metabolic syndrome |
abstract |
A binding reagent capable of specifically binding to the CCR2 chemokine receptor for use in treating a diabetes condition, wherein the binding reagent is immobilized on a solid support contained within an apheresis column, to which blood is applied peripheral blood of a patient thereby extracting the cells expressing CCR2 from the peripheral blood of the patient and wherein the binding reagent is MCP-1. |
priorityDate |
2011-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |